About Planmeca
Planmeca Oy is a Finnish manufacturer of high-tech dental equipment. Established in 1971, it produces equipment such as 3D and 2D digital imaging devices, dental units, CAD/CAM solutions and software.
Planmeca works in close cooperation with dental universities and institutions.
Planmeca’s products are designed and manufactured in Helsinki, Finland, and distributed via a network of dealers operating around the world. More than 98% of Planmeca’s production is exported to over 120 countries.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
Planmeca timeline
- 1971
- 🏁
Events of Planmeca from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
Not enough history yet.
Where Planmeca operates: 2 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
| Country | Presence | Revenue there |
|---|---|---|
| 🇩🇰 Denmark | Headquarters | — |
| 🇫🇮 Finland | 2 offices | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Acquisitions and funding#
1 acquisitions
Businesses it acquired
| Acquired | Acquisition date | Completion | Price | Stake | Source |
|---|---|---|---|---|---|
| KaVo DentalDental technology company | 2022 | — | — | — | Wikidata |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Planmeca🇩🇰 | — | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- UnitedHealth Group Incorporated$367.7 B
- Merck & Co., Inc.$359.8 B
Sources and freshness
- Profile updated:
- Nov 4, 2026
Figures from Wikidata, value.today research, Wikipedia, Wikimedia Commons.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Planmeca? Verify and update this profile — free
Show Planmeca's ranking on your website Get the badge
The badge updates itself as the ranking changes.